Closed transaction
- Advised by
- Client
-
- Counterparty
-
- Deal stage
- Closed transaction
- Service
- Sell
- Sector
- Healthcare
- Sub-sector
- Patient Services
- Market
- EMEA
- Contact
- henrik.westling@evli.com
Deal details
We are pitching to sell VaccinDirekt, a leading chain of vaccination clinics in Sweden and Finland, providing over 500,000 vaccinations per year. 51 vaccination units - 26 clinics and 18 mobile units in Sweden and 5 clinics and 3 mobile units in Finland. The company’s vaccinations offering consists mainly of TBE, Shingrix, influenza and travel vaccines as well as includes health checks and health certificates. Since 2020, Covid 19 vaccination and other related testing are
part of the product offering. The current controlling shareholder is SEB Private Equity. Forecasted sales of approx €36m in 2022 with 16% EBITDA. Ideas of potential international buyers are welcome.
As part of a competitive auction process VaccinDirekt was sold to Swedish based healthcare focused PE fund Impilo.
Deal team
01Members / select to view profile
Henrik Westling
FirmEvli Corporate Finance AB
Henrik joined Evli in May 2002 following Evli’s acquisition of Arthur Andersen’s Nordic Corporate Finance operations.
View profile
Evli Corporate Finance AB latest deals
Sell-side advisory
HUB logistics was sold to Logent.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
Sell-side advisory
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
Sell-side advisory
Nordic Power Service was sold to Ernströmgruppen.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
Equity advisory
IPO of Nokian Panimo.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
More deals in Healthcare
Sell-side advisory
NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.
- Adviser
- INEO Corporate
- Where
- Spain
- Year
- 2026
Sell-side advisory
PharmaX Solutions was sold to BioPhorum.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Sell-side advisory
Nostos Genomics was sold to Limbus Medical Technologies (varvis®).
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2025
Sell-side advisory
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
More deals in Europe
Advisory
houzy and myky join forces under Swiss Digital Home AG.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Sell-side advisory
Fibreactive sold to discoverIE Group plc.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
Buy-side advisory
The Vella Group acquired RGM Vehicle Body Repairs.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
Sell-side advisory
Elite Vehicle Supplies received investment from Vehicle Accessories Solutions Ltd T/A Motormax.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
Membership
Gain worldwide reach with CapFive M&A professionals
The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.
Become a member